PT - JOURNAL ARTICLE AU - Go, Young-Mi AU - Weinberg, Jaclyn AU - Teeny, Sami AU - Cirillo, Piera AU - Krigbaum, Nickilou AU - Singer, Grant AU - Ly, ViLinh AU - Cohn, Barbara AU - Jones, Dean P. TI - Exposome Epidemiology for Suspect Environmental Chemical Exposures during Pregnancy Linked to Subsequent Breast Cancer Diagnosis AID - 10.1101/2023.06.20.23291648 DP - 2023 Jan 01 TA - medRxiv PG - 2023.06.20.23291648 4099 - http://medrxiv.org/content/early/2023/06/27/2023.06.20.23291648.short 4100 - http://medrxiv.org/content/early/2023/06/27/2023.06.20.23291648.full AB - Breast cancer is now the most common cancer globally, accounting for 12% of all new annual cancer cases worldwide. Despite epidemiologic studies having established a number of risk factors, knowledge of chemical exposure risks is limited to a relatively small number of chemicals. In this exposome research study, we used non-targeted, high-resolution mass spectrometry (HRMS) of pregnancy cohort biospecimens in the Child Health and Development Studies (CHDS) to test for associations with breast cancer identified via the California Cancer Registry. Second (T2) and third (T3) trimester archival samples were analyzed from 182 women who subsequently developed breast cancer and 384 randomly selected women who did not develop breast cancer. Environmental chemicals were annotated with the Toxin and Toxin-Target Database (T3DB) for chemical signals that were higher in breast cancer cases and used with an exposome epidemiology analytic framework to identify suspect chemicals and associated metabolic networks. Network and pathway enrichment analyses showed consistent linkage in both T2 and T3 to inflammation pathways, including linoleate, arachidonic acid and prostaglandins, and identified new suspect environmental chemicals associated with breast cancer, i.e., an N-substituted piperidine insecticide and a common commercial product, 2,4-dinitrophenol (DNP), linked to variations in amino acid and nucleotide pathways in T2 and benzo[a]carbazole and a benzoate derivative linked to glycan and amino sugar metabolism in T3. The results identify new suspect environmental chemical risk factors for breast cancer and provide an exposome epidemiology framework for discovery of suspect environmental chemicals and potential mechanistic associations with breast cancer.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Department of Defense Grant W81XWH2010103, and National Institute of Environmental Health and Science grant R21 ES031824, R01 ES031980 and P30 ES019776.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by Institutional Review board (IRB) Human Subjects Review Committee of Public Health Institute (IRB#120-002).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBCbreast cancerFDRfalse discovery rateHRMhigh-resolution metabolomicsHRMShigh-resolution mass spectrometryLC-HRMSliquid chromatography-high resolution mass spectrometryMWASmetabolome-wide association studym/zmass to chargeRTretention timeT2second trimesterT3third trimesterT3DBthe toxin and toxin-targeted database